Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial

In a large, randomised trial, there was no loss of efficacy associated with radiotherapy doses of 24 Gy in indolent NHL and 30 Gy in aggressive NHL, compared with previous standard doses of 40-45 Gy.